JP Morgan Maintains Overweight on Brookfield, Raises Price Target to $47
JP Morgan analyst Kenneth Worthington maintains Brookfield (NYSE:BN) with a Overweight and raises the price target from $46 to $47.
Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.
Credit Suisse Downgrades Brookfield to Neutral, Lowers Price Target to $41
Credit Suisse analyst Andrew Kuske downgrades Brookfield (NYSE:BN) from Outperform to Neutral and lowers the price target from $42 to $41.
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 293 companies set new 52-week lows.